Rapid onset of action of oral labetalol in severe hypertension
- 1 January 1977
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 5 (2) , 147-151
- https://doi.org/10.1185/03007997709110155
Abstract
Nine patients with persistently elevated diastolic blood pressure, exceeding 130 mmHg, received an oral dose of labetalol ranging from 200 mg to 400 mg. In all patients, this produced a significant and gradual decline in recumbent systolic and diastolic blood pressure, unaccompanied by symptoms or complications, with only minor changes in heart rate. Individual variation in the rate of blood pressure fall suggested differences in absorption and first-pass metabolism. It is suggested that the efficacy of oral labetalol merits further investigation in the rapid control of severe hypertension.Keywords
This publication has 4 references indexed in Scilit:
- Rate of onset of hypotensive response with oral labetalol [proceedings]British Journal of Clinical Pharmacology, 1977
- Relationship between plasma concentrations and pharmacological effects of labetalolEuropean Journal of Clinical Pharmacology, 1977
- Assessment of alpha‐ and beta‐adrenoceptor blocking actions of labetalol.British Journal of Clinical Pharmacology, 1976
- Ischaemic brain damage of cerebral perfusion failure type after treatment of severe hypertension.BMJ, 1975